Search

everythinglearnresearchcommunity

for

Search:↓

IL-33 is linked to hair follicle damage in psoriasis and could be a treatment target for hair loss in this condition.

Scientists are still unsure what triggers the immune system to attack hair follicles in Alopecia areata.

Different types of sun exposure damage skin cells and immune cells, with chronic exposure leading to more severe and lasting damage.

People with psoriasis have higher levels of Apelin-13 in their blood than healthy people.

Bexarotene 1% topical gel helped some patients with alopecia areata regrow hair.

Interferons are effective for some skin conditions and cancers, but can have side effects and need more research for optimal use.

Hidradenitis Suppurativa is a chronic skin condition best treated early with surgery for better outcomes and less recurrence.

Hair follicles are normally protected from the immune system, but when this protection fails, it can cause hair loss in alopecia areata.

New therapies are being developed that target integrin pathways to treat various diseases.

Deleting the p63 gene in certain cells causes problems in thymus development and severe hair loss in mice.

A patient with a severe type of hair loss experienced partial hair regrowth after treatment with a specific light therapy and a medication called interferon α2a.

Deleting the BRD4 protein in certain skin cells causes hair loss and skin inflammation.

Geriatric Julia Creek dunnarts often suffer from reproductive and skin diseases, impacting conservation efforts.

Mindfulness reduces anxiety and depression in skin disease patients; dermatologists and psychiatrists often lack confidence in treating psychodermatological conditions.

Treating skin conditions with both psychological and dermatological care improves patient outcomes and can save costs.

Small molecule DMF improves psoriasis and multiple sclerosis, adult skin cells can be made to grow new hair, certain skin cells initiate hair growth, IL-17C controls gut health and can cause skin inflammation, and skin cells produce IL-17 that can lead to psoriasis.

Tofacitinib was more effective than apremilast in treating hair loss in a mouse model of alopecia areata.

Contact immunotherapy can cause vitiligo in patients with autoimmune conditions.

A man's skin cancer improved and some of his hair grew back after treatment with a special light therapy and a medication.

Pure carbon nanotubes are safe for mice, but impure ones cause immune issues and hair loss.

Tebentafusp-tebn improves survival rates in uveal melanoma patients but has common side effects like rash and fatigue.

A protein called lfTSLP is important in causing allergic and other skin diseases and could be a target for treatment.

Nitrogen mustard was not very effective for hair regrowth in alopecia areata and has potential skin cancer risk.

ILC1-like cells may contribute to hair loss in alopecia areata.

Imiquimod cream activates hair follicle stem cells and causes early hair growth by changing immune cells and certain protein expressions.

Thymus transplantation successfully restored immune function in infants with FOXN1 deficiency.

A new vaccine using a porous scaffold boosts immunity and protects against the flu better than traditional methods.

Hair follicle development and microbes help regulatory T cells gather in newborn skin.

Psoriasis may be chronic because it lacks certain immune system controls that prevent overreaction.

Skin changes like hair loss, white patches, and nail changes are common in children after bone marrow transplants, often linked to chronic rejection.